Schizophrenia and HIV

Schizophrenia Bulletin

Volumn 22, Issue 3, 1996, Pages 465-473

  Sewell, Daniel D ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CORRELATION FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA;

EID: 0029834807     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.3.465     Document Type: Review

References (39)

1. Altamura, C.A.; Mauri, M.C.; Coppola, M.T.; Gianetti, S.; and Ferrara, A. "A Follow-up Study in HIV Positive Schizophrenic Patients Treated With Antipsychotic Drugs." Presented at the 7th International Conference on AIDS, Florence, Italy, June 1991.
2. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC: The Association, 1987.
3. Binnie, C.D., and Prior, P.F. Electroencephalography. Journal of Neurology, Neurosurgery and Psychiatry, 57:1308-1319, 1994.
4. Boast, N., and Coid, J. Homosexual erotomania and HIV infection. British Journal of Psychiatry, 164:842-846, 1994.
5. Centers for Disease Control. Classification system for human T-lymphocyte virus type III/lymphadenopathy-associated virus infections. Morbidity and Mortality Weekly Report, 35:334-339, 1986.
6. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance: Case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41:1-19, 1992.
7. Chen, J.L.; Brocavich, J.M.; and Lin, A.Y.F. Psychiatric disturbances associated with ganciclovir therapy. Annals of Pharmacotherapy, 26:193-195, 1992.
8. Cournos, F.; Empfield, M.; Horwath, E.; McKinnon, K.; Meyer, I.; Schrage, H.; Currie, C.; and Agosin, B. HIV seroprevalence among patients admitted to two psychiatric hospitais. American Journal of Psychiatry, 148:1225-1230, 1991.
9. Daif, A.; Obeid, T.; Yaqub, B.; and AbdulJabbar, M. Unusual presentation of tuberculous meningitis. Clinical Neurology and Neurosurgery, 94:1-5, 1992.
10. Dreyer, E.B.; Kaiser, P.K.; Offermann, J.T.; and Lepton, S.A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science, 2:364-367, 1990.
11. Dubovsky, S.L.; Christiano, J.; Daniell, L.C.; Franks, R.D.; Murphy, J.; Adler, L.; Baker, N.I.; and Harris, R.A. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Archives of General Psychiatry, 46:632-638, 1989.
12. El-Mallakh, R.S. Mania in AIDS: Clinical significance and theoretical considerations. International Journal of Psychiatry in Medicine, 21:383-391, 1991.
13. El-Mallakh, R.S. HIV-related psychosis. Journal of Clinical Psychiatry, 53:293-294, 1992.
14. El-Mallakh, R.S., and Jaziri, W.A. Calcium channel blockers in affective illness: Role of sodium-calcium exchange. Journal of Clinical Psychopharmacology, 10:203-206, 1990.
15. El-Mallakh, R.S.; Okoneski, D.; Schapiro, P.; and Ligay, D.J. A neuropsychiatric program for HIV-infected individuals. Maryland Medical Journal, 42:565-570, 1993.
16. Empfield, M.; Cournos, F.; Meyer, I.; McKinnon, K.; Horwath, E.; Silver, M.; Schrage, H.; and Herman, R. HIV seroprevalence among homeless patients admitted to a psychiatric inpatient unit. American Journal of Psychiatry, 150:47-52, 1993.
17. Fernandez, F., and Levy, J.K. The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. General Hospital Psychiatry, 15:31-35, 1993.
18. Halstead, S.; Riccio, M.; Harlow, P.; Oretti, R.; and Thompson, C. Psychosis associated with HIV infection. British Journal of Psychiatry, 153:618-623, 1988.
19. Harris, M.J.; Jeste, D.V.; Gleghorn, A.; and Sewell, D.D. New-onset psychosis in HIV-infected patients. Journal of Clinical Psychiatry, 52:369-376, 1991.
20. Kelly, J.A.; Murphy, D.A.; Bahr, R.; Brasfield, T.L.; Davis, D.R.; Hauth, A.C.; Morgan, M.G.; Stevenson, L.Y.; and Eilers, M.K. AIDS/HIV risk behavior among the chronic mentally ill. American Journal of Psychiatry, 149:886-889, 1992.
21. Markowitz, J.C., and Brown, R.P. Seizures with neuroleptic and antidepressants. General Hospital Psychiatry, 9:135-147, 1987.
22. Masdeu, J.C.; Yudd, A.; Van Heertum, R.L.; Grundman, M.; Hrsio, E.; O'Connell, R.A.; Luck, D.; Camli, U.; and King, L.N. Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: A preliminary report. Journal of Nuclear Medicine, 32:1471-1475, 1991.
23. Masliah, E.; Achim, C.L.; Ge, N.; DeTeresa, R.; Terry, R.D.; and Wiley, C.A. Spectrum of human immunodeficiency virus-associated neocortical damage. Annals of Neurology, 32:321-329, 1992.
24. Navia, B.A.; Jordan, B.D.; and Price, R.W. The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19:517-524, 1986.
25. Ostrow, D.; Grant, I.; and Atkinson, H. Assessment and management of the AIDS patient with neuropsychiatric disturbances. Journal of Clinical Psychiatry, 49(Suppl.):14-22, 1988.
26. Owen, R.R., and Cole, J.O. Molindone hydrochloride: A review of laboratory and clinical findings. Journal of Clinical Psychopharmacology, 9:269-276, 1989.
27. Prier, R.E.; McNeil, J.G.; and Burge, J.R. Inpatient psychiatric morbidity of HIV-infected soldiers. Hospital and Community Psychiatry, 42:619-623, 1991.
28. Richelson, E. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. Journal of Clinical Psychiatry, 5:331-336, 1984.
29. Sacks, M.; Dermatis, H.; Looser-Ott, S.; Burton, W.; and Perry, S. Undetected HIV infection among acutely ill psychiatric inpatients. American Journal of Psychiatry, 149:544-545, 1992.
30. Sewell, D.D.; Jeste, D.V.; Atkinson, J.H.; Heaton, R.K.; Hesselink, J.R.; Wiley, C.; Thal, L.; Chandler, J.L.; Grant, I.; and the San Diego HIV Neurobehavioral Research Center Group. HIV-associated psychosis: A study of 20 cases. American Journal of Psychiatry, 151:237-242, 1994a.
31. Sewell, D.D.; Jeste, D.V.; McAdams, L.A.; Bailey, A.; Harris, M.J.; Atkinson, J.H.; Chandler, J.L.; McCutchan, J.A.; Grant, I.; and the San Diego HIV Neurobehavioral Research Center Group. Neuroleptic treatment of HIV-associated psychosis. Neuropsychopharmacology, 10:223-229, 1994b.
32. Shedlack, K.J.; Soldato-Couture, C.; and Swanson, C.L. Rapidly progressive tardive dyskinsia in AIDS. Biological Psychiatry, 35:147-148, 1994.
33. Sierra-Honigmann, A.M.; Carbone, K.M.; and Yolken, R.H. Polymerase chain reaction (PCR) search for viral nucleic acid sequences in schizophrenia. British Journal of Psychiatry, 166:55-60, 1995.
34. Singh, A.N., and Catalan, J. Risperidone in HIV-related psychosis. Lancet, 344:1029-1030, 1994.
35. Smith, M.C.; Pawar, R.; Carey, J.T.; Graham, R.C.; Jacobs, G.H.; Menon, A.; Salata, R.A.; Seliga, R.; and Kalayjian, R.C. Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy. American Journal of Medicine, 97:145-151, 1994.
36. Torrey, E.F. Surviving Schizophrenia: A Family Manual. New York, NY: Harper & Row, 1988.
37. Trachman, S.B. Buspirone-induced psychosis in a human immunodeficiency virus-infected man. Psychosomatics, 33:332-335, 1992.
38. Tynes, L.L.; Sautter, F.J.; McDermont, B.E.; and Winstead, D.K. Risk of HIV infection in the homeless and chronically mentally ill. Southern Medical Journal, 86:276-281, 1993.
39. Zamperetti, M.; Goldwurm, G.F.; Abbate, E.; Gris, T.; Muratori, S.; and Vigo, B. "Attempted Suicide and HIV Infection: Epidemiological Aspects in a Psychiatric Ward." Presented at the International Conference on AIDS, San Francisco, CA, June 1990.